In the ever-evolving landscape of biopharmaceuticals, companies face the immense challenge of managing regulated data and documents, which has become more complex due to the surge in global regulations. The increasing necessity for a unified Regulatory Information Management (RIM) solution that
Recent developments and analyst perspectives have spotlighted Arbutus Biopharma (NASDAQ: ABUS), indicating a promising growth trajectory for this biopharmaceutical company. Chardan Capital's recent decision to raise its target price for Arbutus Biopharma from $4.00 to $4.50 signifies a potential
Biopharmaceutical fermentation systems are at the forefront of modern medicine, playing a crucial role in the production of biological drugs such as therapeutic proteins, enzymes, monoclonal antibodies, and vaccines. These systems are designed to cultivate microorganisms or cells in controlled
In recent developments, Celltrion USA has significantly expanded the availability of its subcutaneous treatment for Crohn's disease and ulcerative colitis, Zymfentra, now accessible to 26 million patients across the United States. This milestone achievement is a result of the company’s strategic
The recent results of a clinical trial for an oral obesity drug developed by Viking Therapeutics have generated significant interest. The drug has shown promise in early-phase trials, capturing the attention of Wall Street analysts and investors alike. The study results, revealed at a medical
Recent developments in the pharmaceutical industry underscore the volatile nature of advancements and market dynamics affecting prominent companies. The latest updates reveal a mix of struggles and achievements that highlight how pharmaceutical giants are navigating the complexities of drug
The Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is experiencing a transformative period marked by the recent appointment of Michelle Tarver as its new director. Tarver, a clinical ophthalmologist with extensive experience within the FDA, steps into her
MilliporeSigma has announced a substantial $76 million investment to expand its Bioconjugation Center of Excellence in St. Louis, Missouri, aiming to triple its current capacity for Antibody-Drug Conjugates (ADCs). This significant expansion will encompass upgrading 34,000 square feet of existing
Jubilant Radiopharma and Simplified Imaging Solutions (SIS) have announced a strategic partnership aimed at enhancing nuclear medicine services for healthcare providers across the United States. This collaboration is set to create a comprehensive, full-service solution designed to simplify nuclear
In a significant move that aims to revolutionize its IT operations, Alnylam Pharmaceuticals Inc. has entered into a strategic collaboration with Cognizant. This partnership is designed to both transform and scale Alnylam's global infrastructure, cloud, security, platforms, applications, and
